Numerous investigations have provided evidence that abnormal RAB1A expression is a common occurrence in human cancers, such as colorectal cancer [21], GC [23], bladder cancer [24], HCC [34], breast cancer [35], and nasopharyngeal cancer [36]. This evidence concerns the gene RAB1A and colorectal cancer.